Juniper & Ivy Corp 3
3 · AXIM BIOTECHNOLOGIES, INC. · Filed Sep 23, 2022
Insider Transaction Report
Form 3
Juniper & Ivy Corp
10% Owner
Holdings
Series C Preferred Stock
Exercise: $0.00From: 2019-02-20→ Series C Preferred Stock
Footnotes (1)
- [F1]Reporting Person's sole shareholder is John W. Huemoeller, II, the Issuer's Chief Executive Officer and director. Reporting Person holds 500,000 shares of the Issuer's Series C Preferred Stock. Each share of the Issuer's Series C Preferred Stock is: (i) convertible into one (1) share of the Issuer's common stock; and (ii) for voting purposes, is entitled to vote 100 votes per share.